Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joana M Murad

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Best Practice & Research. Clinical Haematology|June 19, 2018
Advances in the use of natural receptor- or ligand-based chimeric antigen receptors (CARs) in haematologic malignanciesJoana M Murad, David J Graber, Charles L Sentman
Blood Cells, Molecules & Diseases|July 22, 2006
PKR activation by a non-coding RNA expressed in lymphocytes of mice bearing B16 melanomaJoana M Murad, Liliana R de Souza, Fernando L De Lucca
Blood Cells, Molecules & Diseases|December 21, 2004
A point mutation in the RNA-binding domain I results in decrease of PKR activation in acute lymphoblastic leukemiaJoana M Murad, Luiz G Tone, Liliana R de Souza, et al.
Current HIV Research|October 28, 2005
Activation of the RNA-dependent protein kinase (PKR) of lymphocytes by regulatory RNAs: implications for immunomodulation in HIV infectionMaria Angelica E Watanabe, Liliana R de Souza, Joana M Murad, et al.
Cytotherapy|December 3, 2023
Human CD4+CD25+ T cells expressing a chimeric antigen receptor against aberrant superoxide dismutase 1 trigger antigen-specific immunomodulationDavid J Graber, W James Cook, Marie-Louise Sentman, et al.
Molecular and Cellular Biochemistry|July 5, 2003
Regulatory RNA induces the production of IFN-gamma, but not IL-4 in human lymphocytes: role of RNA-dependent protein kinase (PKR) and NF-kappaBFernando L De Lucca, Valeria S F Sales, Liliana R Souza, et al.
The Journal of Biological Chemistry|September 11, 2009
ID2 (inhibitor of DNA binding 2) is a rhythmically expressed transcriptional repressor required for circadian clock output in mouse liverTim Y Hou, Sarah M Ward, Joana M Murad, et al.
Cells|September 13, 2025
Human CAR Tregs Targeting SOD1 and Expressing BDNF Reduce Inflammation and Delay Disease in G93A hSOD1-NSG MiceDavid J Graber, W James Cook, Marie-Louise Sentman, et al.
The Journal of Biological Chemistry|May 13, 2010
Inhibitor of DNA binding 4 (ID4) regulation of adipocyte differentiation and adipose tissue formation in miceJoana M Murad, Chelsea S Place, Cong Ran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2016
Mechanisms of Acute Toxicity in NKG2D Chimeric Antigen Receptor T Cell-Treated MiceMarie-Louise Sentman, Joana M Murad, W James Cook, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Best Practice & Research. Clinical Haematology|June 19, 2018
Advances in the use of natural receptor- or ligand-based chimeric antigen receptors (CARs) in haematologic malignanciesJoana M Murad, David J Graber, Charles L Sentman
Blood Cells, Molecules & Diseases|July 22, 2006
PKR activation by a non-coding RNA expressed in lymphocytes of mice bearing B16 melanomaJoana M Murad, Liliana R de Souza, Fernando L De Lucca
Blood Cells, Molecules & Diseases|December 21, 2004
A point mutation in the RNA-binding domain I results in decrease of PKR activation in acute lymphoblastic leukemiaJoana M Murad, Luiz G Tone, Liliana R de Souza, et al.
Current HIV Research|October 28, 2005
Activation of the RNA-dependent protein kinase (PKR) of lymphocytes by regulatory RNAs: implications for immunomodulation in HIV infectionMaria Angelica E Watanabe, Liliana R de Souza, Joana M Murad, et al.
Cytotherapy|December 3, 2023
Human CD4+CD25+ T cells expressing a chimeric antigen receptor against aberrant superoxide dismutase 1 trigger antigen-specific immunomodulationDavid J Graber, W James Cook, Marie-Louise Sentman, et al.
Molecular and Cellular Biochemistry|July 5, 2003
Regulatory RNA induces the production of IFN-gamma, but not IL-4 in human lymphocytes: role of RNA-dependent protein kinase (PKR) and NF-kappaBFernando L De Lucca, Valeria S F Sales, Liliana R Souza, et al.
The Journal of Biological Chemistry|September 11, 2009
ID2 (inhibitor of DNA binding 2) is a rhythmically expressed transcriptional repressor required for circadian clock output in mouse liverTim Y Hou, Sarah M Ward, Joana M Murad, et al.
Cells|September 13, 2025
Human CAR Tregs Targeting SOD1 and Expressing BDNF Reduce Inflammation and Delay Disease in G93A hSOD1-NSG MiceDavid J Graber, W James Cook, Marie-Louise Sentman, et al.
The Journal of Biological Chemistry|May 13, 2010
Inhibitor of DNA binding 4 (ID4) regulation of adipocyte differentiation and adipose tissue formation in miceJoana M Murad, Chelsea S Place, Cong Ran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2016
Mechanisms of Acute Toxicity in NKG2D Chimeric Antigen Receptor T Cell-Treated MiceMarie-Louise Sentman, Joana M Murad, W James Cook, et al.
Pageof 2